Wikidata

(Q65390278)

English

A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
A Randomised, Double Blind, Placebo Controlled, Multicentre Study to Evaluate the Efficacy and Safety of Bevacizumab in Combination With Docetaxel in Comparison With Docetaxel Plus Placebo, as First Line Treatment for Patients With HER2 Negative Metastatic and Locally Recurrent Breast Cancer. (English)
0 references
sponsor
Hoffmann-La Roche
0 references
country
Australia
0 references
Austria
0 references
Belgium
0 references
Brazil
0 references
Canada
0 references
France
0 references
Germany
0 references
Italy
0 references
Lithuania
0 references
Mexico
0 references
Netherlands
0 references
Panama
0 references
Poland
0 references
Portugal
0 references
Romania
0 references
South Africa
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
Taiwan
0 references
Thailand
0 references
United Kingdom
0 references
start time
March 2006
0 references
end time
October 2007
0 references
number of participants
736
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65390278&oldid=2234563090"